| Date Filed | Type | Description |
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2022 |
SC 13G/A
| New Leaf Ventures III, L.P. reports a 9.8% stake in Harpoon Therapeutics, Inc. |
| 02/11/2022 |
SC 13G
| New Leaf Ventures III, L.P. reports a 7.2% stake in Rallybio Corporation |
| 02/11/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/11/2022 |
SC 13G/A
| New Leaf Ventures III, L.P. reports a 2.4% stake in Arvinas, Inc. |
| 02/11/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/15/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/25/2019 |
SC 13D/A
| New Leaf Ventures III, L.P. reports a 2.2% stake in PDS Biotechnology Corporation |
| 02/21/2019 |
SC 13G
| New Leaf Ventures III, L.P. reports a 12.2% stake in Harpoon Therapeutics, Inc. |
| 02/13/2019 |
SC 13G
| New Leaf Ventures III, L.P. reports a 6% stake in Unum Therapeutics Inc. |
| 10/10/2018 |
SC 13G
| New Leaf Ventures III, L.P. reports a 7.1% stake in Arvinas, Inc. |
| 07/03/2018 |
SC 13D
| New Leaf Ventures III, L.P. reports a 9.8% stake in APTINYX INC. |
| 10/11/2017 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 11/02/2015 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 10/13/2015 |
SC 13D
| New Leaf Ventures III, L.P. reports a 8.2% stake in Edge Therapeutics, Inc. |